LONDON (Reuters) - GlaxoSmithKline's (L:GSK) chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly $500 million (323 million pounds) for bribing Chinese doctors.
The group has since been rebuilding its position in China.
The move came as Britain announced the signing of more than 2 billion pounds ($3.1 billion) of healthcare trade deals between Chinese and UK companies, universities and organisations during President Xi Jinping's visit to Britain.
In addition to GSK's Andrew Witty, the China-Britain Business Council said on Wednesday its new 30-strong advisory council would also include WPP (L:WPP) CEO Martin Sorrell, Jaguar Land Rover [TAMOJL.UL] boss Ralf Speth, Rio Tinto (L:RIO) CEO Sam Walsh and HSBC (L:HSBA) Chairman Douglas Flint.